TriSalus Life Sciences (TLSIW) Total Non-Current Liabilities (2022 - 2026)

TriSalus Life Sciences (TLSIW) has 5 years of Total Non-Current Liabilities data on file, last reported at $49.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 10.36% year-over-year to $49.1 million; the trailing twelve-month figure through Mar 2026 stood at $49.1 million (down 10.36% YoY), and the FY2025 full-year result was $59.0 million, up 39.05% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $49.1 million, down from $59.0 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $59.0 million in Q4 2025 and bottomed at $19.6 million in Q3 2023.
• The 5-year median for Total Non-Current Liabilities is $45.1 million (2024), against an average of $44.1 million.
• The widest annual swing landed in 2024, when Total Non-Current Liabilities surged 104.11%; it then slipped 10.36% in 2026.
• A 5-year view of Total Non-Current Liabilities shows it stood at $33.9 million in 2022, then decreased by 2.71% to $33.0 million in 2023, then advanced by 28.56% to $42.5 million in 2024, then jumped by 39.05% to $59.0 million in 2025, then decreased by 16.85% to $49.1 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $49.1 million (Q1 2026), $59.0 million (Q4 2025), and $58.2 million (Q3 2025), per Business Quant data.

Peer Comparison